Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy

BACKGROUND: A substantial number of patients will develop further biochemical progression after radical prostatectomy (RP) and salvage radiotherapy (sRT). Recently published data using prostate-specific membrane antigen ligand positron emission tomography (PSMA - PET) for re-staging suggest that tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Oehus, Ann-Kathrin, Kroeze, Stephanie G. C., Schmidt-Hegemann, Nina-Sophie, Vogel, Marco M. E., Kirste, Simon, Becker, Jessica, Burger, Irene A., Derlin, Thorsten, Bartenstein, Peter, Eiber, Matthias, Mix, Michael, la Fougère, Christian, Belka, Claus, Combs, Stephanie E., Grosu, Anca-Ligia, Müller, Arndt-Christian, Guckenberger, Matthias, Christiansen, Hans, Henkenberens, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191762/
https://www.ncbi.nlm.nih.gov/pubmed/32349700
http://dx.doi.org/10.1186/s12885-020-06883-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191762/
https://www.ncbi.nlm.nih.gov/pubmed/32349700
http://dx.doi.org/10.1186/s12885-020-06883-5

Ejemplares similares